3-183207628-T-C
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 1 ACMG points: 2P and 1B. PM2BP4
The NM_015078.4(MCF2L2):āc.2692A>Gā(p.Ser898Gly) variant causes a missense change. The variant allele was found at a frequency of 0.0000502 in 1,613,904 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Genomes: š 0.000046 ( 0 hom., cov: 33)
Exomes š: 0.000051 ( 0 hom. )
Consequence
MCF2L2
NM_015078.4 missense
NM_015078.4 missense
Scores
8
11
Clinical Significance
Conservation
PhyloP100: 5.10
Genes affected
MCF2L2 (HGNC:30319): (MCF.2 cell line derived transforming sequence-like 2) Predicted to enable guanyl-nucleotide exchange factor activity. Predicted to be involved in regulation of catalytic activity. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 1 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.36961183).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MCF2L2 | NM_015078.4 | c.2692A>G | p.Ser898Gly | missense_variant | 23/30 | ENST00000328913.8 | NP_055893.4 | |
MCF2L2 | XM_017005943.3 | c.2692A>G | p.Ser898Gly | missense_variant | 23/26 | XP_016861432.2 | ||
MCF2L2 | XM_011512585.3 | c.1633A>G | p.Ser545Gly | missense_variant | 15/22 | XP_011510887.1 | ||
MCF2L2 | XM_047447751.1 | c.1591A>G | p.Ser531Gly | missense_variant | 14/21 | XP_047303707.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MCF2L2 | ENST00000328913.8 | c.2692A>G | p.Ser898Gly | missense_variant | 23/30 | 5 | NM_015078.4 | ENSP00000328118 | A2 | |
MCF2L2 | ENST00000473233.5 | c.2692A>G | p.Ser898Gly | missense_variant | 23/29 | 5 | ENSP00000420070 | P4 | ||
MCF2L2 | ENST00000468976.5 | n.73A>G | non_coding_transcript_exon_variant | 1/6 | 4 | |||||
MCF2L2 | ENST00000488149.5 | n.7139A>G | non_coding_transcript_exon_variant | 24/28 | 2 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152266Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
7
AN:
152266
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000120 AC: 3AN: 250992Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135642
GnomAD3 exomes
AF:
AC:
3
AN:
250992
Hom.:
AF XY:
AC XY:
2
AN XY:
135642
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000506 AC: 74AN: 1461638Hom.: 0 Cov.: 33 AF XY: 0.0000536 AC XY: 39AN XY: 727146
GnomAD4 exome
AF:
AC:
74
AN:
1461638
Hom.:
Cov.:
33
AF XY:
AC XY:
39
AN XY:
727146
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152266Hom.: 0 Cov.: 33 AF XY: 0.0000672 AC XY: 5AN XY: 74402
GnomAD4 genome
AF:
AC:
7
AN:
152266
Hom.:
Cov.:
33
AF XY:
AC XY:
5
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
2
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 26, 2022 | The c.2692A>G (p.S898G) alteration is located in exon 23 (coding exon 23) of the MCF2L2 gene. This alteration results from a A to G substitution at nucleotide position 2692, causing the serine (S) at amino acid position 898 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T
MetaSVM
Benign
T
MutationAssessor
Uncertain
M;M
MutationTaster
Benign
D;D
PrimateAI
Benign
T
PROVEAN
Uncertain
D;D
REVEL
Benign
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
P;.
Vest4
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at